Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

DWSBIOO:GR

225.27 EUR 12.20 5.14%

As of 01:59:30 ET on 03/26/2015.

Snapshot for DWS Biotech (DWSBIOO)

Year To Date: +22.24% 3-Month: +22.30% 3-Year: +47.84% 52-Week Range: 108.86 - 251.02
1-Month: +3.21% 1-Year: +83.24% 5-Year: +32.71% Beta vs NBI: 0.95

Mutual Fund Chart for DWSBIOO

No chart data available.
  • DWSBIOO:GR 225.27
  • 1M
  • 1Y
Interactive DWSBIOO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DWSBIOO

DWS Biotech is an open-end fund incorporated in Germany. The Fund's objective is capital growth. The Fund invests primarily in biotech equities worldwide. The Fund focuses on companies in the U.S. and the portfolio may also include selected pharmaceutical and medical equipment firms. The Fund's investment is oriented on the MSCI BioTecnology Select Index.

Inception Date: 08-16-1999 Telephone: Tel. 49-1803-10111011
Managers: NOUSHIN IRANI TURNER / HOLGER GEISSLER
Web Site: www.dws.de

Fundamentals for DWSBIOO

NAV (on 2015-03-26) 225.27
Assets (M) (on 2015-03-26) 548.37
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment -

Dividends for DWSBIOO

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-10-01) 0.02
Dividend Yield (ttm) 0.01

Fees & Expenses for DWSBIOO

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.70

Top Fund Holdings for DWSBIOO

Filing Date: 12/30/2014
Name Position Value % of Total
Celgene Corp 378,000 35,541,221 9.126%
Gilead Sciences Inc 368,000 29,410,982 7.552%
Biogen Inc 103,658 29,240,845 7.509%
Amgen Inc 215,010 28,760,424 7.385%
Vertex Pharmaceuticals Inc 215,637 21,217,427 5.448%
Alexion Pharmaceuticals Inc 110,800 17,174,478 4.410%
Illumina Inc 110,188 17,153,831 4.405%
BioMarin Pharmaceutical Inc 220,000 16,662,861 4.279%
Incyte Corp 202,346 12,342,366 3.169%
Regeneron Pharmaceuticals Inc 34,000 11,558,241 2.968%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil